Clinical trial
Evaluation of the Usefulness of Induced Sputum Eosinophilia, eNO and Bronchial Hyperresponsiveness in Predicting the Failure of Inhaled Corticosteroids Dose Reduction in Children and Adolescents With Stable Asthma
NCT03788057 is registered in ClinicalTrials.gov with National Institute for Tuberculosis and Lung Diseases, Poland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Usefulness of Induced Sputum Eosinophilia, eNO and Bronchial Hyperresponsiveness in Predicting the Failure of Inhaled Corticosteroids Dose Reduction in Children and Adolescents With Stable Asthma
- Lead sponsor
- National Institute for Tuberculosis and Lung Diseases, Poland
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2016
- Completion date
- March 31, 2019
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asthma chronic